UK markets closed

Sarepta Therapeutics, Inc. (SRPT)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
133.66+3.03 (+2.32%)
At close: 04:00PM EDT
134.90 +1.24 (+0.93%)
After hours: 06:01PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts13131415
Avg. Estimate-0.051.013.3910.8
Low estimate-0.430.040.530.52
High estimate0.542.596.325.35
Year ago EPS-0.27-0.46-5.83.39
Revenue estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts17162020
Avg. Estimate384.38M495.97M1.88B2.8B
Low estimate365.6M406.91M1.57B1.67B
High estimate435M705.54M2.42B4.4B
Year ago sales261.24M331.82M1.24B1.88B
Sales growth (year/est)47.10%49.50%50.80%49.50%
Earnings history29/06/202329/09/202330/12/202330/03/2024
Est. EPS-1.78-1.230.01-0.07
Actual EPS-0.27-0.460.470.37
Difference1.510.770.460.44
Surprise %84.80%62.60%4,600.00%628.60%
EPS trendCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Current estimate-0.051.013.3910.8
7 days ago-0.130.62.2910.55
30 days ago-0.060.722.3710.94
60 days ago0.020.742.4710.5
90 days ago0.340.853.039.82
EPS revisionsCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Up last 7 days88107
Up last 30 days89106
Down last 7 daysN/AN/AN/AN/A
Down last 30 days6658
Growth estimatesSRPTIndustrySector(s)S&P 500
Current qtr.81.50%N/AN/AN/A
Next qtr.319.60%N/AN/AN/A
Current year158.40%N/AN/AN/A
Next year218.60%N/AN/AN/A
Next 5 years (per annum)96.00%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A